Medical Marijuana Market to Register CAGR 16.1% Increase in Revenue by 2026 End

The medical marijuana market is anticipated to record a year-over-year growth rate of 15.9% and reach a market value of US$ 39,891.2 Mn by 2026. Extract form segment is expected to have high revenue share, accounting for 63.9% share in 2018 of the overall medical marijuana market. In this report, the medical marijuana market is segmented based on product type, application type, distribution channel and region.

The extract form is the dominant segment in the market for medical marijuana as maximum number of products are made out of extract form and they are conveniently used by majority of the population. The product listed include oil concentration, tinctures, sprays, edibles, tablets, and capsules based on prescription. In contrast, the companies conduct research activities to introduce novel products in the market.

What the report encloses for the readers:

  • Critical insights of each segment, including volume growth outlook, and demand & supply pattern.
  • A to Z of each player –positives & negatives, current status, future developments – of the global market.
  • Detailed information regarding the trends influencing the growth of the global market.
  • In-depth assessment on the utilization in the industry.
  • Historical data and future growth outlook of the global market.

Report Highlights:

  • Shifting Industry dynamics
  • In-depth market segmentation
  • Historical, current and projected industry size Recent industry trends
  • Key Competition landscape
  • Strategies of key players and product offerings
  • Potential and niche segments/regions exhibiting promising growth
  • A neutral perspective towards market performance

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/13897

Company Profiles

  • Aphria Incorporation
  • The Peace Naturals Project
  • Aurora Cannabis Inc
  • Canopy Growth Corporation
  • CANNABIS SATIVA, INC.
  • Green Relief Inc.
  • GW PHARMACEUTICALS PLC
  • Insys Therapeutics, Inc.
  • Medical Marijuana, Inc.
  • MedReleaf Corporation

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/13897

In terms of revenue, the extract segment is expected to account for large revenue share of 63.9% in 2018, is expected to witness significant growth during the forecast period. The growth in the dried flower segment is expected to be primarily driven by traditional use and purpose of usage with options available to consume dry form medical marijuana without any interventions.

Pain management seems to be the preferred choice to use medical marijuana, as the segment includes pain associated with many diseases such as cancer, arthritis, AIDS, multiple sclerosis, and nerve damage, among others. The common practice associated with the routine checks involve the dynamic use of medical marijuana.

Others segment has a range of indications in which medical marijuana is used such as PTSD, anxiety, mental health conditions, and many more. However, the seizures segment which involves cases of multiple sclerosis, Parkinson’s disease, and convulsions is expected to witness high CAGR of 16.1% during the forecast period.

The retail pharmacy distribution segment is expected to hold maximum share in the overall medical marijuana market due to the large number of companies forming dispensaries of their own to sell the products on a major scale. Retail pharmacy is the first choice of distribution among manufacturers and consumers.

Retail pharmacy distribution segment is estimated to have a market share of 77.9% in 2018 and a steady growth the E-commerce is also expected in the medical marijuana market due to change in operational functions that offer a high growth rate during the forecast period.

Medical marijuana is well known for its notorious qualities that are being projected in different communities around the world. It is not in use by majority of the global population for medical cases. In the U.S., marijuana is classified as a schedule 1 controlled substance, which makes it illegal to consume or possess.

Access Full Report @ https://www.persistencemarketresearch.com/checkout/13897

Limited use of medical marijuana has latched on to claims that it is useful to treat various ailments such as Crohn’s disease, multiple sclerosis results into muscle spasm, epilepsy, glaucoma, and nausea, among others. Though the medical marijuana is being synthesized to be used for medical purposes, the legalization of recreational marijuana would have some serious effects on overall marijuana pricing.

Recreational marijuana is not subjected to be in use for health reasons, but are often consumed for its soothing and psychotic nature. But with developments for medical marijuana usage for medical purpose are on a rise in both developing and developed countries, progress with medical marijuana consumption in severe health issues often makes it a noticeable choice for physicians to prescribe it to treat diseases. Besides, there must be solid evidence to make it rather official to be in use.

Conventional medicines are becoming expensive with time, whereas the adult population is increasing, which fails to adapt to this dynamic shift.

PMR’s report has segmented the global medical marijuana market on the basis of region into North America, Europe, Latin America, Asia Pacific Excluding China, China and Middle East & Africa. This report assesses trends driving each market segment and offers analysis and insights about the medical marijuana market in specific regions.

North America is expected to account major share in the global medical marijuana market and it is expected to grow at a CAGR of 16.2% being the most lucrative regional market for medical marijuana. Europe is expected to follow North America during the forecast period due to high prevalence of cases that require medical marijuana for the treatment.

Explore Extensive Coverage of PMR`s Life Sciences & Transformational Health Landscape

Liquid Chromatographymass Spectroscopy Market – Liquid Chromatography-Mass Spectroscopy Segmented By Triple Quadrupole, Time of Flight, Quadrupole Technology in Clinical Testing, Environmental Testing, Forensic Testing. For More Information 

Biopharmaceutical Market – Biopharmaceuticals Market Segmented By Monoclonal Antibodies, Recombinant Proteins, Granulocyte-Colony Stimulating Factor, Interferons, Recombinant Human Insulin, Erythropoietin, Vaccines, Growth Hormones, Purified Proteins Type for Metabolic Disorders, Oncology, Neurological Disorders, Cardiovascular Diseases, Inflammatory and Infectious Diseases. For More Information

About us:

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMR’s collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.

Contact us:

305 Broadway, 7th Floor
New York City, NY 10007
United States
Ph.no. +1-646-568-7751
E-mail id- sales@persistencemarketresearch.com
Website: https://www.persistencemarketresearch.com

Leave a Reply

Your email address will not be published. Required fields are marked *